Diagnostic options · UAE

Oncology Genetics tests in Dubai & UAE

Compare available Oncology Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Oncology Genetics test prices

Showing 1–15 of 17 matching tests.

Oncology Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1854 AML Panel Deletion/Duplication Detection Test This test evaluates the presence of deletions or duplications in specific genes commonly associated with Acute Myeloid Leukemia (AML).	Bone Marrow Aspirate or Peripheral Blood	7–10 days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene deletions", "Gene duplications", "AML-associated genes"] Parameters [] Preparation [] Indications ["Diagnosis of AML", "Prognosis assessment in AML", "Guidance for targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 93385-0 ICD-10: C92.00 Clinical summary This test evaluates the presence of deletions or duplications in specific genes commonly associated with Acute Myeloid Leukemia (AML).
TEST-650 Chronic Lymphocytic Leukemia (CLL) Mutations Detection Panel 2 Test This test detects key genetic mutations and copy number variations in CLL-associated genes to guide treatment and risk stratification.	Peripheral Whole Blood (EDTA tube, lavender-top)	6–7 Days (Sample Mon, Report Sat)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TP53 mutations", "NOTCH1 mutations", "SF3B1 mutations", "11q deletion (copy number variation)"] Parameters [] Preparation ["Complete the mandatory Genomics Clinical Information Requisition Form (Form 20).", "Ensure the whole blood sample is collected in a lavender-top EDTA tube."] Indications ["Diagnosis of CLL", "Prognosis assessment in CLL", "Guiding treatment selection in CLL", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 88214-7 ICD-10: C91.1 Clinical summary This test detects key genetic mutations and copy number variations in CLL-associated genes to guide treatment and risk stratification.
TEST-1625 Epidermal Growth Factor Receptor (EGFR) Mutation Analysis (Exons 18–21) Test This test detects specific mutations in the EGFR gene (exons 18-21) relevant to targeted cancer therapy.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block, Biopsy Slides, or Surgical Pathology Cuts	3–4 Working Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EGFR gene mutations (SNVs, indels)", "Exon 18, 19, 20, 21 variants"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of NSCLC", "Guidance for TKI therapy selection", "Prognostic information"] Measurement technique Confirm with laboratory Codes LOINC: 5827-7 ICD-10: C34.9, Z85.1 Clinical summary This test detects specific mutations in the EGFR gene (exons 18-21) relevant to targeted cancer therapy.
TEST-1615 EWSR1 Gene Rearrangement (Ewing Sarcoma) Test This diagnostic test evaluates for specific chromosomal translocations involving the EWSR1 gene, characteristic of Ewing sarcoma.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue	7–8 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EWSR1 gene rearrangement", "Chromosomal translocation t(11;22)(q24;q12)"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Valid doctor’s prescription is mandatory"] Indications ["Diagnosis of Ewing sarcoma", "Differentiation of small round blue cell tumors", "Guiding targeted therapy", "Clinical trial eligibility assessment"] Measurement technique Confirm with laboratory Codes LOINC: 60515-0 ICD-10: C41.9 Clinical summary This diagnostic test evaluates for specific chromosomal translocations involving the EWSR1 gene, characteristic of Ewing sarcoma.
TEST-1255 FLT3 Gene Mutation Test This test detects specific mutations (ITD and TKD) in the FLT3 gene, which are important prognostic markers and therapeutic targets in acute myeloid leukemia.	5 mL Whole Blood in EDTA (Lavender Top) or Bone Marrow Aspirate	7 Days (1 Week)	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLT3-ITD mutations", "FLT3-TKD mutations"] Parameters [] Preparation ["No fasting required."] Indications ["Diagnosis of acute myeloid leukemia (AML)", "Risk stratification in AML", "Guidance for targeted therapy selection in AML"] Measurement technique Confirm with laboratory Codes LOINC: 49956-1 ICD-10: C92.00 Clinical summary This test detects specific mutations (ITD and TKD) in the FLT3 gene, which are important prognostic markers and therapeutic targets in acute myeloid leukemia.
TEST-2061 KIT Gene Familial Gastrointestinal Stromal Tumor (GIST) Genetic Test This test analyzes the KIT gene for pathogenic variants associated with hereditary gastrointestinal stromal tumors (GIST). It identifies individuals at increased risk for developin...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the KIT gene"] Parameters [] Preparation ["Provide a detailed clinical history", "Attend a genetic counseling session to draw a family pedigree chart"] Indications ["Individuals with a family history of GIST", "Personal history of GIST", "Cascade screening for family members of GIST patients"] Measurement technique Confirm with laboratory Codes LOINC: 53727-8 ICD-10: Z15.09 Clinical summary This test analyzes the KIT gene for pathogenic variants associated with hereditary gastrointestinal stromal tumors (GIST). It identifies individuals at increased risk for developing GIST.
TEST-1426 Liquid Biopsy Cell-Free KRAS Mutation Analysis (cfDNA KRAS) Test This test identifies the presence and specific type of KRAS gene mutations in circulating tumor DNA (ctDNA) within a patient's blood plasma.	Plasma (from peripheral blood)	5–7 working days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KRAS gene mutations", "Circulating tumor DNA (ctDNA)"] Parameters [{"name": "KRAS Mutation Status", "reference_range": "Negative / Positive (Specific Mutation)"}] Preparation ["A doctor’s prescription is mandatory", "Avoid heavy meals and strenuous exercise 2 hours before blood collection", "Inform phlebotomist of any blood-thinning medications"] Indications ["Monitoring treatment response in cancer patients", "Detecting resistance mutations", "Guiding targeted therapy selection (e.g., anti-EGFR)", "Non-invasive cancer monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 88233-7 ICD-10: C80.0, C18.9, C34.9 Clinical summary This test identifies the presence and specific type of KRAS gene mutations in circulating tumor DNA (ctDNA) within a patient's blood plasma.
TEST-1432 Liquid Biopsy Cell‑Free BRAF Mutation Analysis Test This test detects the presence of specific BRAF V600E/K mutations in circulating tumor DNA (ctDNA) within a blood sample.	Peripheral Blood Plasma (ctDNA)	5–7 Working Days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF V600E mutation", "BRAF V600K mutation", "Circulating cell-free tumor DNA (ctDNA)"] Parameters [] Preparation ["No fasting is required.", "Continue all prescribed medications unless your oncologist specifically instructs otherwise."] Indications ["Monitoring oncologic therapy", "Early recurrence detection", "Guiding targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 92821-8 ICD-10: C43.9, Z85.9 Clinical summary This test detects the presence of specific BRAF V600E/K mutations in circulating tumor DNA (ctDNA) within a blood sample.
TEST-1993 MPL Gene Exon 10 NGS Sequencing Test This test identifies somatic or germline mutations in exon 10 of the MPL gene.	Peripheral Whole Blood (EDTA) or Isolated DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MPL gene exon 10 mutations", "Variant Allele Frequency (VAF)"] Parameters [] Preparation ["No fasting required", "Continue all prescribed medications unless advised otherwise by your doctor"] Indications ["Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Diagnosis of familial thrombocytosis", "Risk stratification in myeloproliferative neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 93111-7 ICD-10: D47.3, D47.1 Clinical summary This test identifies somatic or germline mutations in exon 10 of the MPL gene.
TEST-2129 NRAS Gene Mutation Analysis for Hereditary Colorectal Cancer Test This test evaluates the full coding region of the NRAS gene for pathogenic variants associated with hereditary colorectal cancer risk.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NRAS oncogene"] Parameters [{"name": "NRAS Gene Full Sequencing", "reference_range": null}] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Hereditary CRC Risk Assessment", "Family Screening", "Targeted Therapy Guidance"] Measurement technique Confirm with laboratory Codes LOINC: 93027-1 ICD-10: Z80.3 Clinical summary This test evaluates the full coding region of the NRAS gene for pathogenic variants associated with hereditary colorectal cancer risk.
TEST-1962 NRAS Gene Sequencing (Exons 2‑3) Test This test identifies mutations within exons 2 and 3 of the NRAS gene using next-generation sequencing.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spots (FTA Card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NRAS gene mutations", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Mandatory genetic counselling session", "Provide detailed three-generation family pedigree", "Obtain informed consent", "Provide complete current medication list"] Indications ["Targeted cancer therapy guidance", "Hereditary cancer risk assessment", "Melanoma", "Colorectal adenocarcinoma"] Measurement technique Confirm with laboratory Codes LOINC: 46035-3 ICD-10: Z15.09, Z13.71 Clinical summary This test identifies mutations within exons 2 and 3 of the NRAS gene using next-generation sequencing.
TEST-1254 PDGFR Mutation Screening (Exons 12, 14, 18) Test This test detects activating mutations in the PDGFRA gene exons 12, 14, and 18, which are key drivers in certain GIST cases.	Archival Tissue Specimen — Formalin-Fixed Paraffin-Embedded (FFPE) Block or Fresh Frozen Tumor Tissue	7–8 Working Days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFRA gene mutations", "Activating mutations in exons 12, 14, 18"] Parameters [{"name": "Analytical Precision", "reference_range": ">99.9% per-base accuracy; bidirectional exon coverage"}] Preparation ["Valid doctor's prescription required", "Original histopathology report required"] Indications ["Diagnosis of GIST", "KIT-wildtype GIST", "Guidance for targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 92105-9 ICD-10: Z13.89 Clinical summary This test detects activating mutations in the PDGFRA gene exons 12, 14, and 18, which are key drivers in certain GIST cases.
TEST-1217 PIK3CA Mutation Analysis (Exon 7, 9 & 20) Test This test identifies somatic mutations in exons 7, 9, and 20 of the PIK3CA gene within tumor tissue.	Archival tissue specimen (FFPE block, biopsy slides, or surgical pathology cuts)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in PIK3CA gene exons 7, 9, and 20"] Parameters [] Preparation [] Indications ["Guiding precision oncology in breast cancer", "Guiding precision oncology in endometrial cancer", "Guiding precision oncology in other PIK3CA-related cancers"] Measurement technique Confirm with laboratory Codes LOINC: 81253-0 ICD-10: C50.9, C54.1 Clinical summary This test identifies somatic mutations in exons 7, 9, and 20 of the PIK3CA gene within tumor tissue.
TEST-1209 PML/RARA Quantitative [Single Form] Test This test quantitatively measures the PML/RARA fusion transcript, a genetic marker specific to Acute Promyelocytic Leukemia (APL). It is used for diagnosis, MRD monitoring, and tre...	Peripheral Whole Blood (EDTA); Bone Marrow Aspirate if clinically indicated	2–3 Business Days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PML/RARA fusion transcript (t(15;17))", "Minimal Residual Disease (MRD)"] Parameters [{"name": "PML/RARA Fusion Transcript", "reference_range": "Undetectable (or quantitative value reported)"}] Preparation ["No special dietary or medication preparation is required for a peripheral blood draw.", "Patients scheduled for bone marrow aspiration must follow fasting instructions and medication adjustment guidelines provided by their hematologist."] Indications ["Diagnosis of suspected Acute Promyelocytic Leukemia (APL)", "Monitoring treatment response in APL patients", "Detection of Minimal Residual Disease (MRD) in APL", "Prediction of relapse in APL"] Measurement technique Confirm with laboratory Codes LOINC: 76490-6 ICD-10: C92.4 Clinical summary This test quantitatively measures the PML/RARA fusion transcript, a genetic marker specific to Acute Promyelocytic Leukemia (APL). It is used for diagnosis, MRD monitoring, and treatment response assessment.
TEST-1171 RB1 Gene Deletion & Duplication Detection (Retinoblastoma) Test This test detects large genomic rearrangements (deletions or duplications) within the RB1 gene.	Peripheral whole blood	7–10 working days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RB1 gene deletions", "RB1 gene duplications"] Parameters [] Preparation [] Indications ["Diagnosis of retinoblastoma", "Assessment of familial risk for retinoblastoma", "Identifying at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 68956-0 ICD-10: Z13.71 Clinical summary This test detects large genomic rearrangements (deletions or duplications) within the RB1 gene.

Category overview

Oncology Genetics: overview

A family history of cancer can weigh heavily on your mind, but gaining precise genetic insights offers a powerful path to proactive health management. Within our Molecular Diagnostics division, our Oncology Genetics testing uses advanced DNA sequencing to evaluate inherited markers linked to various malignancies. Rather than providing a standalone clinical diagnosis, this essential oncology genetics data equips your healthcare provider with the clarity needed for tailored, preventive medical guidance. As one of the top diagnostic labs in Dubai and the UAE, DNA Labs UAE ensures strict patient confidentiality and incredibly fast, accurate turnaround times. Take charge of your future well-being: explore our oncology genetics testing in the UAE below to book your test, arrange a seamless home sample collection, or consult our experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.